In addition, participants with NAFLD had higher serum levels of ALT, glucose, HOMA-IR, TG and UA, and lower physical activity and HDL-C levels than non-NAFLD subjects in both females and males (all p <  0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.